News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2025 Michael O'Riordan June 30, 2025
News Daily News FDA Approves Triple Therapy Polypill for High Blood Pressure Michael O'Riordan June 10, 2025
News Conference News ESC 2024 Polypills Show Promise in Diverse Hypertensive Patient Groups L.A. McKeown August 31, 2024
News Daily News Dietary Salt Linked to AF Risk in Patients With Vascular Disease or Diabetes L.A. McKeown July 11, 2024
News Daily News ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study Michael O'Riordan July 27, 2021
News Daily News Nighttime Hypertension Drug Dosing May Reduce Risk of CVD L.A. McKeown October 23, 2019
News Daily News ARB Use Linked to Suicide in New Study, but Is the Finding Real? Michael O'Riordan October 18, 2019
News Daily News TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction Shelley Wood August 15, 2018
News Conference News ACC 2018 Low-Dose, Three-Drug Polypill TRIUMPHs for Blood Pressure Shelley Wood March 12, 2018
News Conference News ACC 2018 ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More Shelley Wood March 12, 2018
News Daily News Substantial BP Reductions Appear to Lower Stroke Risk Safely in CAD Patients Todd Neale November 02, 2014
News Daily News El Bloqueador de la Angiotensina Preserva la Función Endotelial Mejor que el Antagonista del Calcio Jason Kahn March 05, 2012
News Daily News Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist Jason Kahn March 05, 2012
Presentation Protective Effect of Telmisartan Against Endothelial Dysfunction After Coronary DES Implantation in Hypertensive Patients Presenter: Mitsuyasu Terashima February 29, 2012